Attached files
file | filename |
---|---|
EX-99.1 - EX-99.1 - LIBERATOR MEDICAL HOLDINGS, INC. | g22205exv99w1.htm |
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 22, 2010
LIBERATOR MEDICAL HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
NEVADA | 000-05663 | 87-0267292 | ||
(State or other jurisdiction Of incorporation) |
(Commission File Number) |
(IRS Employer Identification Number) |
2979 SE Gran Park Way, Stuart, Florida 34997
(Address of Principal Executive Offices)
(772) 287-2414
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligations of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
TABLE OF CONTENTS
ITEM 7.01 REGULATION FD DISCLOSURE | ||||||||
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS | ||||||||
SIGNATURES | ||||||||
EX-99.1 |
Table of Contents
ITEM 7.01 REGULATION FD DISCLOSURE
On February 22, 2010, Ladenburg Thalman & Co., Inc., initiated coverage of Liberator Medical
Holdings, Inc., with a Buy Rating. A copy of the initial coverage report is filed as Exhibit 99.1
to this Report on Form 8-K.
The information under this caption, Item 7.01 Regulation FD Disclosure, including information
in any related exhibits, is being furnished to the Securities and Exchange Commission and shall not
be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or
otherwise subject to the liability of that Section. This information shall not be deemed
incorporated by reference in any filing under the Securities Act of 1933, as amended, except as
shall be expressly set forth by specific reference in such a filing.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits
Exhibit No. | Description | |||||||||||||||||||||||||||||||||||||||||||
99.1
|
Ladenburg Thalman & Co., Inc., Initial Coverage Report provided on February 22, 2010. |
2
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
LIBERATOR MEDICAL HOLDINGS, INC. Registrant |
||||
Dated: February 22, 2010 | /s/ Mark A. Libratore | |||
Mark A. Libratore, President | ||||
3